Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-17-031197)

Filing Details

Accession Number:: 0001209191-17-031197
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-05-10 15:12:40
Reporting Period:: 2017-05-10

Filing Date:: 2017-05-10
Accepted Time:: 2017-05-10 15:12:40
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1510580	Kite Pharma Inc.	KITE	Biological Products, (No Disgnostic Substances) (2836)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1674528	L Paul Jenkinson	C/O Kite Pharma, Inc. 2225 Colorado Avenue Santa Monica CA 90404	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2017-05-10	450	$72.57	7,480	No	4	P	Direct
Common Stock	Acquisiton	2017-05-10	3,000	$72.59	3,000	No	4	P	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Indirect	See footnote

Footnotes

Includes 430 shares acquired under the 2014 Employee Stock Purchase Plan on February 17, 2017.
The shares are held by The Amended & Restated Paul and Monika Jenkinson Family Trust Dated July 25, 2012.